Drug prescription study of bronchial asthma patients in a tertiary-care hospital in Bangladesh
Publiée 2021-09-21
Mots-clés
- Bronchial asthma,
- prescription monitoring,
- anti-asthma medications
(c) Copyright The Planet 2019
Ce travail est disponible sous la licence Creative Commons Attribution 4.0 International .
Comment citer
Résumé
Background: Ideally bronchial asthma is treated according to standard asthma guidelines, but it is the knowledge, Attitude and Practice is responsible for appropriate application of standard asthma guidelines. The purpose of present study is to evaluate the drug prescription pattern of anti-asthma medications as outdoor follow up in a tertiary-care hospital. Many medications are now available for the treatment of asthma and selection of proper treatment is essential. Materials and Methods: The prescription data from 125 bronchial asthma patients were studied using a prescription auditing proforma. Data was recorded from the patients attending the outpatient department of Sher-E-Bangla Medical College Hospital, Barishal from January to June 2019, through convenient sampling. Verbal consent was taken from all patients before included in the proforma. Iniatialy 125 patients were included but only 100 prescriptions were monitored for data analysis as per the inclusion and exclusion criteria. Results: The results of the study revealed maximum patients were in the age of 31 – 40 years; 67% male and 33% female. Majority of the patients received multiple drug therapy as compared with individual drug therapy. Combination of salmeterol and fluticasone through inhalational route were prescribed in majority of patients. 63% patients received drugs through inhalational route.
Conclusion: It is concluded that the present prescribing trends of anti-asthma medications in SBMCH does not completely meet standard guidelines of asthma treatment. There is need to
encourage physicians of SBMCH to treat asthma patients according to national guidelines.
Références
- National Guidelines Asthma, 3rd Edition 2005, Asthma Association Bangladesh.
- Shaji J, Lodha S. Management of Asthma: A Review. Indian J Hosp Pharmacy 2008;45:88-100
- Mishra N, Rao KVR, Padhi Sk. Asthma education for better compliance in disease management. Indian J Allergy Asthma Immunol 2005; 19:25-8
- American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatr. 2006; 118(4):1774–1793. doi: https://doi.org/10.1542/peds.2006-2223
- Barnes PJ. Pulmonary pharmacology. In: Brunton LL, Chabner BA, KnollmannBC(Eds.).Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 12th edn. New York: McGraw-Hill, 2011. pp. 1031–57.
- Dartnell J. Activities to improve hospital prescribing. Australian Prescriber. 2001;24:29–31. [Google Scholar]
- George J, Senthilkumar AB, Rajendran SD, Suresh B. Drug prescribing audit of ranitidine: a government hospital experience. Indian J Pharmaceut Sci. 2001;63:491–9.
- Ungar WJ, Coyte PC. Prospective study of the patient level cost of asthma care in children. Pediatr Pulmonol 2001;32:101-8
- Shimpi RD, Salunkhe PS, Bavaskar SR, Laddha GP, Kalam A. Khalil Patel A. Drug utilization evaluation and prescription monitoring in asthmatic patients. IJPBS. 2012;2:117-122
- A. Awanish Pandey. Prescription pattern in asthma therapt at Gorakhpur hospitals. Lung India. 2010 Jan-Mar; 27(1): 8-10.
- National Heart, Lung, and Blood Institute, National Institutes of Health. International Consensus Report on the Diagnosis and Treatment of Asthma. Bethesda: National Heart, Lung, and Blood Institute, National Institutes of Health, March 1992. Publication no. 92-
- NIH. Guidelines for the Diagnosis and Management of Asthma. Bethesda: National Institutes of Health (NIH), May 1997. p. 41 Publication no. 97-4051 A.
- National Heart, Lung and Blood Institute, WHO. Global Strategy for Asthma Management and Prevention. Bethesda: NHLBI/WHO workshop, 1997. NIH Publication no. 974051.
